Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.

This study aimed to assess the safety and efficacy of using high dose melphalan and etoposide followed by autologous, non-cryopreserved marrow rescue in advanced Hodgkin's disease (HD). Seventeen patients with poor risk Hodgkin's disease from a single centre underwent autologous bone marro...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, P. R., Jackson, G. H., Lennard, A. L., Lucraft, H., Proctor, S. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968195/
https://www.ncbi.nlm.nih.gov/pubmed/8431371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968195/
https://www.ncbi.nlm.nih.gov/pubmed/8431371

Ejemplares similares